European Disease Progression Monitor: Edition 4

Legacy brands can form the foundation of a successful business, particularly for specialized players with the appropriate organizational structure and the…

L.E.K. Consulting and Galen Growth conducted a survey of ~90 industry leaders in Q4 2019 to assess the digital readiness of healthcare sectors and…

After more than 25 years of investment, commercialization of gene therapies (GTs) has reached a pivotal point.

After a faltering start, Japan’s biosimilars marketplace appears on the cusp of rapid growth.

The L.E.K. Global Situation Report is a uniquely rich, current, and customisable collection of indicators that provide a powerful recovery planning aide.

L.E.K. Consulting reviews progress to date, outlines barriers to uptake and identifies potential catalysts for accelerating European CAR-T adoption.